Cue Biopharma (CUE) Net Margin (2018 - 2026)
Cue Biopharma (CUE) recorded Net Margin of -1943.21% in Q2 2026, down 1656.08 percentage points from -287.14% a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Net Margin (2018 - 2026) Analysis & Trends
On a TTM basis, Cue Biopharma's Net Margin came in at -479.39% as of Jun 30, 2026, down 10.04 percentage points year-over-year; for FY2025, it came in at -96.85%, up 341.11 percentage points from FY2024.
- Annual Net Margin has increased for three straight years, with a five-year change of +1322.94 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -437.97% in FY2024 (+486.13 pp), -924.10% in FY2023 (+3333.73 pp), -4257.83% in FY2022 (-3962.27 pp) and -295.56% in FY2021 (+1124.23 pp).
- The Q2 2026 figure is the lowest quarterly Net Margin since Q1 2025.
- On a year-over-year basis, Net Margin rose in four of the last seven quarters, with an average year-over-year change of -404.35 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 49845.95 percentage points in Q2 2023, against a drop of 50424.72 percentage points in Q2 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 19.55% |
| 10 | Cue Biopharma | 98.10 Mn | 18.47 Mn | - | -1,943.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,943.21% |
| Mar 31, 2026 | -91.07% |
| Dec 31, 2025 | 7.22% |
| Sep 30, 2025 | -346.58% |
| Jun 30, 2025 | -287.14% |
| Mar 31, 2025 | -2,911.40% |
| Dec 31, 2024 | -602.54% |
| Sep 30, 2024 | -259.59% |
| Jun 30, 2024 | -382.66% |
| Mar 31, 2024 | -719.10% |
| Dec 31, 2023 | -737.73% |
| Sep 30, 2023 | -524.05% |
| Jun 30, 2023 | -954.05% |
| Mar 31, 2023 | -7,010.16% |
| Dec 31, 2022 | -9,663.58% |
| Sep 30, 2022 | -16,110.29% |
| Jun 30, 2022 | -50,800.00% |
| Mar 31, 2022 | -1,425.50% |
| Dec 31, 2021 | -101.57% |
| Sep 30, 2021 | -542.51% |
API Access
Cue Biopharma Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();